missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. 18429007

IL-27R alpha/WSX-1/TCCR Antibody (MM0563-8A5), Janelia Fluor™ 549, Novus Biologicals™

Mouse Monoclonal Antibody

Brand:  Novus Biologicals NBP2-11917JF549

Product Code. 18429007

  • € 628.00 / 0.10mL

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

IL-27R alpha/WSX-1/TCCR Monoclonal antibody specifically detects IL-27R alpha/WSX-1/TCCR in Human samples. It is validated for Western Blot
TRUSTED_SUSTAINABILITY
Specifications

Specifications

IL-27R alpha/WSX-1/TCCR
Monoclonal
Janelia Fluor 549
50mM Sodium Borate
Mouse
Protein G purified
RUO
Primary
Human, Primate
Purified
Western Blot, Immunohistochemistry, Immunofluorescence
MM0563-8A5
Western Blot
class I cytokine receptor, CRL1IL-27R, Cytokine receptor-like 1, IL27R, IL-27RA, IL-27R-alpha, interleukin 27 receptor, alpha, interleukin-27 receptor subunit alpha, TCCRIL-27 receptor subunit alpha, T-cell cytokine receptor type 1, Type I T-cell cytokine receptor, WSX-1, WSX1IL-27R subunit alpha, zcytor1
Human recombinant IL-27R alpha/WSX-1/TCCR (extracellular domain)
0.1 mL
Apoptosis, Cytokine Research
9466
Store at 4C in the dark.
IgG2
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.